Close Menu

NEW YORK ─ Siemens Healthineers said on Thursday that its SARS-CoV-2 total antibody test was the only one of four assays in a head-to-head study that met Target Product Profile (TPP)-sensitivity criteria for immunoassays established by the UK Medicines and Healthcare products Regulatory Agency.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.